Company intelligence / Profile preview

Segmed

Palo Alto, California, United Statessegmed.ai ↗

Ownership: Private
Employees: ~32
Development stage: Commercial

Overview

Segmed provides at-scale access to regulatory-grade, de-identified medical imaging datasets and multimodal health records. Their solutions are used in clinical trial design, biomarker discovery, external control arms for trials, post-marketing surveillance, and AI algorithm development. The company’s datasets have powered R&D in pharma and medtech sectors globally.

Therapeutic areas: OncologyOther
Modalities: DeviceData platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Bayer Radiology

Beyond the preview

Go deeper on Segmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Segmed.

Explore the full profile